Kintsugi Therapeutics is a preclinical biopharmaceutical company focused on the development of drugs for the treatment of metabolic and neurodegenerative diseases.
Kintsugi Therapeutics has raised €1.0M across 1 funding round from 1 investor, most recently a Crowdfunding round in Nov 2021. Based in Barcelona, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-11 | Crowdfunding |
| €1.0M |
| Capital Cell |
| View deal → |
